Matrix Capital Management Exits Aura Biosciences with $39M Share Repurchase
AURA sits 88% above its 52-week low of $4.345.
Summary
Aura Biosciences completed a $39 million share repurchase from Matrix Capital Management, marking the investment firm's full exit as a shareholder.
Key Events · Ownership and Investor Activity · AURA
-
Major Share Repurchase Completed
Aura Biosciences repurchased 6,922,870 shares of common stock from Matrix Capital Management Company LP at $5.64 per share, totaling approximately $39.04 million. This transaction was completed on May 7, 2026, following a definitive agreement announced on May 4, 2026.
-
Significant Investor Exits
Matrix Capital Management Company LP, a former 10% owner, has fully divested its stake in Aura Biosciences. This Schedule 13D/A serves as an "exit filing" for the reporting persons, indicating they no longer hold any shares.
Analysis · AURA · Life Sciences
This filing confirms the completion of Aura Biosciences' repurchase of 6.92 million shares from Matrix Capital Management Company LP for $39 million. This transaction, previously announced in an 8-K on May 4, 2026, marks the complete exit of Matrix Capital Management as a significant shareholder. The repurchase reduces the outstanding share count and follows recent capital raises, indicating the company's active capital management.
At the time of this filing, AURA was trading at $8.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $525.8M. The 52-week trading range was $4.35 to $9.54. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.